Home › Entities › doctoral_thesis › Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy

Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy

2016 doctoral thesis by Kan Kaneko at University of Otago
Place doctoral_thesis Q112931131
Press Enter · cited answer in seconds

Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy

Summary

Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy is a doctoral thesis[1].

Key Facts

  • Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy authored Kan Kaneko[2].
  • Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy's instance of is recorded as doctoral thesis[3].
  • Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy's publisher is recorded as OUR Archive[4].
  • Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy's language of work or name is recorded as English[5].
  • Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy's country of origin is recorded as New Zealand[6].
  • Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy's publication date is recorded as +2016-00-00T00:00:00Z[7].
  • Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy's main subject is recorded as nanoparticle[8].
  • Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy's main subject is recorded as vaccine[9].
  • Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy's main subject is recorded as mouth[10].
  • Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy's main subject is recorded as alpha-galactosylceramide[11].
  • Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy's Handle ID is recorded as 10523/6334[12].
  • Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy's title is recorded as Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy[13].
  • Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy's copyright holder is recorded as Kan Kaneko[14].
  • Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy's thesis submitted to is recorded as University of Otago[15].
  • Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy's on focus list of Wikimedia project is recorded as NZThesisProject[16].
  • Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy's copyright status is recorded as copyrighted[17].
  • Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy's thesis committee member is recorded as Sarah Hook[18].
  • Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy's thesis committee member is recorded as Arlene McDowell[19].

Body

Designation and Status

Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy's instance of is recorded as doctoral thesis[3].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [3] ↑ . wikidata.org.
  2. [2] ↑ . hdl.handle.net. hdl.handle.net. Provenance: wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . hdl.handle.net. hdl.handle.net. Provenance: wikidata.org.
  8. [9] ↑ . hdl.handle.net. hdl.handle.net. Provenance: wikidata.org.
  9. [10] ↑ . hdl.handle.net. hdl.handle.net. Provenance: wikidata.org.
  10. [11] ↑ . hdl.handle.net. hdl.handle.net. Provenance: wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.
  16. [17] ↑ . wikidata.org.
  17. [18] ↑ . wikidata.org.
  18. [19] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy. Retrieved May 3, 2026, from https://4ort.xyz/entity/evaluation-of-oral-particulate-formulations-containing-galactosylceramide-for-the-treatment-of-allergy
MLA “Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/evaluation-of-oral-particulate-formulations-containing-galactosylceramide-for-the-treatment-of-allergy.
BibTeX @misc{4ortxyz_evaluation-of-oral-particulate-formulations-containing-galactosylceramide-for-the-treatment-of-allergy_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy}}, year = {2026}, url = {https://4ort.xyz/entity/evaluation-of-oral-particulate-formulations-containing-galactosylceramide-for-the-treatment-of-allergy}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Evaluation of oral particulate formulations containing α-galactosylceramide for the treatment of allergy — https://4ort.xyz/entity/evaluation-of-oral-particulate-formulations-containing-galactosylceramide-for-the-treatment-of-allergy (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/evaluation-of-oral-particulate-formulations-containing-galactosylceramide-for-the-treatment-of-allergy · Last refreshed: